One of the first reports of HIF1α upregulation in leukemia came from studies in chronic myeloid leukemia (CML), where it was observed that BCR-ABL induces HIF1α mRNA and protein expression downstream PI3K/mTOR activation (68). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.